Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

NCT00587873 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Disease

Interventions

DRUG: Methotrexate
DRUG: Leucovorin calcium
DRUG: 6-Thioguanine

Sponsor

Memorial Sloan Kettering Cancer Center